Jul. 28, 2017
Toxicologist witness called first in talc trial
A board-certified pharmacologist and toxicologist testifying as the plaintiff’s first witness in the Johnson & Johnson talcum bellwether trial said Thursday that using the powder produces “an inflammatory response” that leads to cancer.
LOS ANGELES — A board-certified pharmacologist and toxicologist testifying as the plaintiff’s first witness in the Johnson & Johnson talcum bellwether trial said Thursday that using the powder produces “an inflammatory response” that leads to cancer.
Laura Plunkett testified in the Los Angeles County Superior Court trial that talc can migrate to the ovaries and cause inflammation that could lead to developing ovarian cancer.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In